Answers are grounded in this paper and cite their sources.
Retrospective study identifies paravermal lesions in X-ALD, suggesting significant imaging and clinical correlations.
BACKGROUND AND PURPOSE: X-linked adrenoleukodystrophy (X-ALD) is an ABCD1-related peroxisomal disorder characterized by the accumulation of very-long-chain fatty acids and heterogeneous neurological manifestations. Paravermal lesions, defined as T2-weighted and FLAIR hyperintense abnormalities in the cerebellar white matter adjacent to the vermis, have been reported in neuronal intranuclear inclusion disease (NIID), fragile X-associated tremor/ataxia syndrome (FXTAS), and dentatorubral-pallidoluysian atrophy (DRPLA). We observed similar MRI findings in patients with X-ALD; however, their frequency and associated imaging features and clinical features have not been systematically evaluated. Therefore, the purpose of this study was to determine the frequency and associated imaging features and clinical features of paravermal lesions on brain MRI in patients with genetically confirmed X-ALD. MATERIALS AND METHODS: We retrospectively identified 95 patients with genetically confirmed X-ALD at our institution. After excluding patients who had not undergone brain MRI, 87 patients were included in the final study cohort. Clinical records were reviewed for cerebellar symptoms. MRI findings were independently evaluated by a trainee radiologist and a board-certified diagnostic radiologist. Disagreements were resolved by consensus. Loes scores were assessed in all cases. Between-group comparisons were performed using the Mann–Whitney U test for continuous variables and Fisher’s exact test for categorical variables. RESULTS: All 87 patients were male (median age, 33.0 years [interquartile range, 27.0–44.5 years]). The median Loes score was 2.0 (interquartile range, 0.0–6.8). Paravermal lesions were found in 23/87 (26.4%) patients, most commonly with bilateral involvement. Patients with paravermal lesions had significantly higher Loes scores than those without (median, 7.5 vs 0.0; P < .001), and cerebellar atrophy was significantly more frequent in the lesion-positive group (16/23 [69.6%] vs 4/64 [6.3%]; P < .001). Paravermal lesions were also associated with cerebellar symptoms (15/23 [65.2%] vs 12/64 [18.8%]; P < .001). CONCLUSIONS: Paravermal lesions were observed in 26.4% of patients with genetically confirmed X-ALD and were associated with higher Loes scores, cerebellar atrophy, and cerebellar symptoms. Recognition of this imaging pattern may prompt consideration of X-ALD, in addition to NIID, FXTAS, and DRPLA, in the appropriate clinical context.
No takes yet. Share an insight, caveat, or question.
Sato et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: